Cargando…

TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway

OBJECTIVES: The aim of our study was to investigate the role of TrkB pathway in tumor occurrence and development for in order to provide theoretical basis to laryngeal cancer therapy. MATERIALS AND METHODS: Biological characteristics of the cells were studied by migration tests and colony forming as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Liang, Wang, Zhihai, Liu, Chuan, Gong, Zhitao, Yang, Yucheng, Kang, Houyong, Li, Yanshi, Hu, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752476/
https://www.ncbi.nlm.nih.gov/pubmed/29312563
http://dx.doi.org/10.18632/oncotarget.21711
_version_ 1783290112489029632
author Jiang, Liang
Wang, Zhihai
Liu, Chuan
Gong, Zhitao
Yang, Yucheng
Kang, Houyong
Li, Yanshi
Hu, Guohua
author_facet Jiang, Liang
Wang, Zhihai
Liu, Chuan
Gong, Zhitao
Yang, Yucheng
Kang, Houyong
Li, Yanshi
Hu, Guohua
author_sort Jiang, Liang
collection PubMed
description OBJECTIVES: The aim of our study was to investigate the role of TrkB pathway in tumor occurrence and development for in order to provide theoretical basis to laryngeal cancer therapy. MATERIALS AND METHODS: Biological characteristics of the cells were studied by migration tests and colony forming assay. Gene and protein expression analysis was performed by RT-PCR or western blot. in vivo experiments were conducted in syngeneic BALB/c mice. RESULTS: Significant changes in protein and gene expression, including higher expression level of TrkB, were found in cells and laryngeal cancer specimens. we demonstrated that TrkB activates AKT via c-Src, leading to increased proliferation. Also, TrkB induced EMT via increased expression of EMT related transcription factors such as Twist-1 and Twist-2. CONCLUSION: Our data indicate TrkB are overexpressed in laryngeal cancer, and TrkB signaling is involved in tumorigenicity of laryngeal cancer. These observations suggest that TrkB is a promising target for future intervention strategies to prevent tumor metastasis, EMT program in laryngeal cancer. What is already known about this subject? • Cancer of the larynx is one of the most common types of head and neck cancer. • The survival rate of advanced laryngeal cancer is only 30 to 40%. • The tropomyosin-related kinase B receptor (TrkB), together with TrkA and TrkC, are neurotrophin receptors regulating the proliferation and differentiation of neuronal cells. What are the new findings? • TrkB are overexpressed in laryngeal cancer. • TrkB signaling is involved in tumorigenicity of laryngeal cancer. • TrkB acts as a key regulator of the PI3K/AKT signal pathway-mediated tumor metastasis. How might these results change the focus of research or clinical practice? • These observations suggest that TrkB is a promising target for future intervention strategies to prevent tumor metastasis, EMT program in laryngeal cancer. Our study provides molecular insight into the tumor metastasis and has important implications in elucidating oncogenic processes.
format Online
Article
Text
id pubmed-5752476
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57524762018-01-08 TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway Jiang, Liang Wang, Zhihai Liu, Chuan Gong, Zhitao Yang, Yucheng Kang, Houyong Li, Yanshi Hu, Guohua Oncotarget Research Paper OBJECTIVES: The aim of our study was to investigate the role of TrkB pathway in tumor occurrence and development for in order to provide theoretical basis to laryngeal cancer therapy. MATERIALS AND METHODS: Biological characteristics of the cells were studied by migration tests and colony forming assay. Gene and protein expression analysis was performed by RT-PCR or western blot. in vivo experiments were conducted in syngeneic BALB/c mice. RESULTS: Significant changes in protein and gene expression, including higher expression level of TrkB, were found in cells and laryngeal cancer specimens. we demonstrated that TrkB activates AKT via c-Src, leading to increased proliferation. Also, TrkB induced EMT via increased expression of EMT related transcription factors such as Twist-1 and Twist-2. CONCLUSION: Our data indicate TrkB are overexpressed in laryngeal cancer, and TrkB signaling is involved in tumorigenicity of laryngeal cancer. These observations suggest that TrkB is a promising target for future intervention strategies to prevent tumor metastasis, EMT program in laryngeal cancer. What is already known about this subject? • Cancer of the larynx is one of the most common types of head and neck cancer. • The survival rate of advanced laryngeal cancer is only 30 to 40%. • The tropomyosin-related kinase B receptor (TrkB), together with TrkA and TrkC, are neurotrophin receptors regulating the proliferation and differentiation of neuronal cells. What are the new findings? • TrkB are overexpressed in laryngeal cancer. • TrkB signaling is involved in tumorigenicity of laryngeal cancer. • TrkB acts as a key regulator of the PI3K/AKT signal pathway-mediated tumor metastasis. How might these results change the focus of research or clinical practice? • These observations suggest that TrkB is a promising target for future intervention strategies to prevent tumor metastasis, EMT program in laryngeal cancer. Our study provides molecular insight into the tumor metastasis and has important implications in elucidating oncogenic processes. Impact Journals LLC 2017-10-09 /pmc/articles/PMC5752476/ /pubmed/29312563 http://dx.doi.org/10.18632/oncotarget.21711 Text en Copyright: © 2017 Jiang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Jiang, Liang
Wang, Zhihai
Liu, Chuan
Gong, Zhitao
Yang, Yucheng
Kang, Houyong
Li, Yanshi
Hu, Guohua
TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
title TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
title_full TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
title_fullStr TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
title_full_unstemmed TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
title_short TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway
title_sort trkb promotes laryngeal cancer metastasis via activation pi3k/akt pathway
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752476/
https://www.ncbi.nlm.nih.gov/pubmed/29312563
http://dx.doi.org/10.18632/oncotarget.21711
work_keys_str_mv AT jiangliang trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT wangzhihai trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT liuchuan trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT gongzhitao trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT yangyucheng trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT kanghouyong trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT liyanshi trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway
AT huguohua trkbpromoteslaryngealcancermetastasisviaactivationpi3kaktpathway